» Articles » PMID: 23554675

Gender-based Differences in Cardiac Diseases

Overview
Journal J Biomed Res
Specialty General Medicine
Date 2013 Apr 5
PMID 23554675
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

It has been observed that the incidence of heart failure and Brugada syndrome are higher in men, while women are more likely to have QT interval prolongation and develop torsades de pointes (TdP). Over the past decade, new studies have improved our understanding of the mechanisms of abnormal repolarization and the relationship between gender differences in cardiac repolarization and presentation of clinical syndromes. Nevertheless, the causes of gender-based differences in cardiac disease are still not completely clear. This review paper briefly summarized what is currently known about gender differences in heart failure, Brugada syndrome and long QT syndrome from molecular mechanisms to clinical presentations.

Citing Articles

Credibility assessment of in silico clinical trials for medical devices.

Pathmanathan P, Aycock K, Badal A, Bighamian R, Bodner J, Craven B PLoS Comput Biol. 2024; 20(8):e1012289.

PMID: 39116026 PMC: 11309390. DOI: 10.1371/journal.pcbi.1012289.


Transgenic Rabbit Models in Proarrhythmia Research.

Baczko I, Hornyik T, Brunner M, Koren G, Odening K Front Pharmacol. 2020; 11:853.

PMID: 32581808 PMC: 7291951. DOI: 10.3389/fphar.2020.00853.


Sex-Dependent QRS Guidelines for Cardiac Resynchronization Therapy Using Computer Model Predictions.

Lee A, ORegan D, Gould J, Sidhu B, Sieniewicz B, Plank G Biophys J. 2019; 117(12):2375-2381.

PMID: 31547974 PMC: 6990372. DOI: 10.1016/j.bpj.2019.08.025.


Exome-chip meta-analysis identifies novel loci associated with cardiac conduction, including ADAMTS6.

Prins B, Mead T, Brody J, Sveinbjornsson G, Ntalla I, Bihlmeyer N Genome Biol. 2018; 19(1):87.

PMID: 30012220 PMC: 6048820. DOI: 10.1186/s13059-018-1457-6.


miR-494 Contributes to Estrogen Protection of Cardiomyocytes Against Oxidative Stress Targeting (NF-κB) Repressing Factor.

Tang Z, Zhao W, Du J, Ni X, Zhu X, Lu J Front Endocrinol (Lausanne). 2018; 9:215.

PMID: 29867756 PMC: 5960695. DOI: 10.3389/fendo.2018.00215.


References
1.
Redfield M, Jacobsen S, Burnett Jr J, Mahoney D, Bailey K, Rodeheffer R . Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003; 289(2):194-202. DOI: 10.1001/jama.289.2.194. View

2.
Wu Z, Chen K, Haendler B, McDonald T, Bian J . Stimulation of N-terminal truncated isoform of androgen receptor stabilizes human ether-á-go-go-related gene-encoded potassium channel protein via activation of extracellular signal regulated kinase 1/2. Endocrinology. 2008; 149(10):5061-9. PMC: 5398425. DOI: 10.1210/en.2007-1802. View

3.
Croft J, Giles W, Pollard R, Keenan N, Casper M, Anda R . Heart failure survival among older adults in the United States: a poor prognosis for an emerging epidemic in the Medicare population. Arch Intern Med. 1999; 159(5):505-10. DOI: 10.1001/archinte.159.5.505. View

4.
Vasan R, Larson M, Benjamin E, Evans J, Reiss C, Levy D . Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999; 33(7):1948-55. DOI: 10.1016/s0735-1097(99)00118-7. View

5.
Liu X, Katchman A, Whitfield B, Wan G, Janowski E, Woosley R . In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits. Cardiovasc Res. 2002; 57(1):28-36. DOI: 10.1016/s0008-6363(02)00673-9. View